Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300 over six years. Read why LGND stock is a Buy.
Ligand Pharma (LGND) stock jumped in the final week of June, but the proximate cause was the pricing of $625M of convertible ...
The fair value price target for XOMA Royalty has been reset from US$65.75 to US$39.00, now aligned with the agreed all cash ...
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and ...
View Ligand Pharmaceuticals Incorporated LGND stock quote prices, financial information, real-time forecasts, and company news from CNN.
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and ...
This sell reduced Ligand Pharmaceuticals from 5.8% to 4.8% of Ashford Capital Management’s 13F reportable AUM. Top holdings after the filing: NASDAQ:GSAT: $51.3 million (5.7% of AUM) NASDAQ:LGND: ...
Ligand Pharmaceuticals shares were 8% lower, at $254.01, after the company said it plans to offer $550 million of convertible senior notes due 2031 in a private placement. Ligand said it expects to ...
In biology, the binding of cellular proteins to molecules called ligands produces myriad functions essential for life, including cell signaling and enzymatic action. In biotechnology and medicine, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results